I hold a degree in Medical and Pharmaceutical Biotechnology and completed my PhD in Molecular Biology in April 2024, through a joint programme between King’s College London and the University of Trieste.

During my doctoral studies, I worked on two main projects: investigating the role of oral and gut microbiota in pediatric autism spectrum disorder, and exploring the interactions between ACE2, TMEM16s, and the SARS-CoV-2 Spike protein.

I am currently a postdoctoral researcher in Fred Warren’s group, where I’ve returned to the field I’m most passionate about. My work, in collaboration with two different start-ups, focuses on in vitro digestion models and the effects of dietary fibres and probiotics on the microbiota, short-chain fatty acid production, and hormone regulation.

Key publications

miR-96 and miR-183 differentially regulate neonatal and adult postinfarct neovascularization
DOI: 10.1172/jci.insight.134888

Trichoplein binds PCM1 and controls endothelial cell function by regulating autophagy
DOI: 10.15252/embr.201948192